Short stature due to a defect in growth hormone receptor or post receptor pathway (Q97202): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Síndrome de insensibilidade ao hormônio do crescimento (SIGH) é um grupo de doenças caracterizado por baixa estatura importante associada a concentrações normais ou elevadas de hormônio do crescimento (GH), que não responde à administração exógena de GH. SIGH compreende atraso de crescimento devido a deficiência de IGF-1, atraso de crescimento devido a resistência ao IGF-1, síndrome de Laron, baixa estatura devido a deficiência de STAT5b e deficiência primária de subunidade ácido-lábil (ALS). (veja estes termos)
description / endescription / en
 
Growth hormone insensitivity syndrome (GHIS) is a group of diseases characterised by marked short stature associated with normal or elevated growth hormone (GH) concentrations, which fail to respond to exogenous GH administration. GHIS comprises growth delay due to IGF-1 deficiency, growth delay due to IGF-1 resistance, Laron syndrome, short stature due to STAT5b deficiency and primary acid-labile subunit (ALS) deficiency (see these terms).

Revision as of 13:15, 16 August 2026

Growth hormone insensitivity syndrome (GHIS) is a group of diseases characterised by marked short stature associated with normal or elevated growth hormone (GH) concentrations, which fail to respond to exogenous GH administration. GHIS comprises growth delay due to IGF-1 deficiency, growth delay due to IGF-1 resistance, Laron syndrome, short stature due to STAT5b deficiency and primary acid-labile subunit (ALS) deficiency (see these terms).
Language Label Description Also known as
default for all languages
ID_510125881
    English
    Short stature due to a defect in growth hormone receptor or post receptor pathway
    Growth hormone insensitivity syndrome (GHIS) is a group of diseases characterised by marked short stature associated with normal or elevated growth hormone (GH) concentrations, which fail to respond to exogenous GH administration. GHIS comprises growth delay due to IGF-1 deficiency, growth delay due to IGF-1 resistance, Laron syndrome, short stature due to STAT5b deficiency and primary acid-labile subunit (ALS) deficiency (see these terms).

      Statements